Evidence map›Paper›PMID 31350832›Full record

ReviewMicrobiology spectrum2019

Gabriel T Mashabela, Timothy J de Wet, Digby F Warner

Abstract readReview
In one paragraph

Review in Microbiology spectrum, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Article
  2. Mechanisms ofBreathe (Sheffield, England) · 2026
    Review
  3. Review
  4. Review
  5. Article
  6. Inorganic sulfate is critical forProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Vitamin BMicrobiology spectrum · 2024
    Article
  13. Article
  14. Article
  15. Review
  16. Target Identification in Anti-Tuberculosis Drug Discovery.International journal of molecular sciences · 2023
    Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Gabriel T MashabelaSAMRC/NHLS/UCT Molecular Mycobacteriology Research Unit, DST/NRF Centre of Excellence for Biomedical TB Research, Department of Pathology and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, South Africa.
Timothy J de WetSAMRC/NHLS/UCT Molecular Mycobacteriology Research Unit, DST/NRF Centre of Excellence for Biomedical TB Research, Department of Pathology and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, South Africa.
Digby F WarnerSAMRC/NHLS/UCT Molecular Mycobacteriology Research Unit, DST/NRF Centre of Excellence for Biomedical TB Research, Department of Pathology and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, South Africa.

Funding

Replisome dynamics in M tuberculosis_linking persistence to genetic resistanceU01HD085531 · NICHD · UNIVERSITY OF CAPE TOWN · PI WARNER, DIGBY FRANCIS, WOODGATE, ROGER · 2015 to 2019
$1.1M
Drug permeation and activity in Mycobacterium tuberculosis infected macrophagesR21AI115993 · NIAID · UNIVERSITY OF CAPE TOWN · PI RUSSELL, DAVID G, WARNER, DIGBY FRANCIS · 2015 to 2016
$314k
NIAID NIH HHS R21 AI115993NICHD NIH HHS U01 HD085531
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsAntitubercular AgentsHumansMetabolic Networks and PathwaysMycobacterium tuberculosisTuberculosisVirulenceAntitubercular Agents

Identifiers

PMID31350832
PMCPMC10957194

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.